MedPath
NMPA Approval

Nabumetone Oral Suspension

国药准字H20041576

January 4, 2024

Drug Information

萘丁美酮干混悬剂

弘旭来

弘旭来

口服混悬剂

1.0g

化学药品

January 4, 2024

Company Information

Applicant Company

江西省南昌市高新技术产业开发区高新区火炬大街789号

Manufacturing Company

江西省南昌市高新技术产业开发区火炬大街789号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

萘丁美酮干混悬剂 - NMPA 批准文号 | MedPath